Company / Profit Margin
CRISPR Therapeutics AG Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-16569.8%
FY2025
5-year range
-54271.7% / 41.3%
FY2021-FY2025
Trend
-1588.1%
vs FY2024
Sector context
#142 of 143
Health Care
What the data says
Profit Margin changed -1588% YoY in FY2025, a notable deviation from the 9-year average annual change of -15343%.
Based on SEC 10-K filings.
-16569.8% in FY2025 with a 5-year CAGR of +31951.1%.
Declined from -41.4% to -16569.8% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +37701.9pp
- 5-Year Change
- +31951.1pp
- 10-Year Change
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 143This company -16569.8% Sector average -899.4%
▼
-1742.3% below sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 1588.1% year-over-year.
- Currently 15670.4pp below the Health Care sector average.
- Peak profit margin was recorded in FY2019.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -16569.8% | -1588.1% |
| FY2024 | -981.5% | -2272.0% |
| FY2023 | -41.4% | +99.9% |
| FY2022 | -54271.7% | -131572.1% |
| FY2021 | 41.3% | +100.1% |
| FY2020 | -48520.9% | -338.0% |
| FY2019 | 20383.5% | +486.0% |
| FY2018 | -5281.1% | -3067.3% |
| FY2017 | -166.7% | +62.8% |
| FY2016 | -448.8% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026